Registro:

Referencias:

• Mor, G., Cardenas, I., The immune system in pregnancy: a unique complexity (2010) Am J Reprod Immunol, 63, pp. 425-433
• Redman, C.W.G., Sargent, I.L., Immunology of pre-eclampsia (2010) Am J Reprod Immunol, 63, pp. 534-543
• Dekel, N., Gnainsky, Y., Granot, I., Mor, G., Inflammation and implantation (2010) Am J Reprod Immunol, 63, pp. 17-21
• Moser, G., Gauster, M., Orendi, K., Glasner, A., Theuerkauf, R., Huppertz, B., Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models (2010) Hum Reprod, 25, pp. 1127-1136
• Fitzgerald, J.S., Germeyer, A., Huppertz, B., Jeschke, U., Knöfler, M., Moser, G., Scholz, C., Markert, U.R., Governing the invasive trophoblast: current aspects on intra- and extracellular regulation (2010) Am J Reprod Immunol, 63, pp. 492-505
• Burton, G.J., Jauniaux, E., Charnock-Jones, D.S., Human early placental development: potential roles of the endometrial glands (2007) Placenta, 28 (SUPPL. A), pp. S64-S69
• Daher, S., de Arruda Geraldes Denardi, K., Blotta, M.H., Mamoni, R.L., Reck, A.P., Camano, L., Mattar, R., Cytokines in recurrent pregnancy loss (2004) J Reprod Immunol, 62, pp. 151-157
• Clark, D.A., Yu, G., Arck, P.C., Levy, G.A., Gorczynski, R.M., MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome (2003) Am J Reprod Immunol, 49, pp. 297-307
• Kwak-Kim, J., Yang, K.M., Gilman-Sachs, A., Recurrent pregnancy loss: a disease of inflammation and coagulation (2009) J Obstet Gynaecol Res, 35, pp. 609-622
• Girardi, G., Yarilin, D., Thurman, J.M., Holers, V.M., Salmon, J.E., Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction (2006) J Exp Med, 203, pp. 2165-2175
• Gomez-Lopez, N., Guilbert, L.J., Olson, D.M., Invasion of the leukocytes into the fetal-maternal interface during pregnancy (2010) J Leukoc Biol, 88, pp. 625-633
• Ashkar, A.A., Di Santo, J.P., Croy, B.A., Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy (2000) J Exp Med, 192, pp. 259-270
• van den Heuvel, M.J., Xie, X., Tayade, C., Peralta, C., Fang, Y., Leonard, S., Paffaro Jr., V.A., Croy, B.A., A review of trafficking and activation of uterine natural killer cells (2005) Am J Reprod Immunol, 54, pp. 322-331
• Harris, L.K., IFPA Gabor Than Award lecture: transformation of the spiral arteries in human pregnancy: key events in the remodelling timeline (2011) Placenta, 32 (SUPPL. 2), pp. S154-S158
• Moffett-King, A., Natural killer cells and pregnancy (2002) Nat Rev Immunol, 2, pp. 656-663
• Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Mandelboim, O., Decidual NK cells regulate key developmental processes at the human fetal-maternal interface (2006) Nat Med, 12, pp. 1065-1074
• Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation (2008) Nat Rev Immunol, 8, pp. 958-969
• Strazewski Chavez, S.L., Abrahams, V.M., Mor, G., The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy (2005) Endocr Rev, 26, pp. 877-897
• Fest, S., Aldo, P.B., Abrahams, V.M., Visintin, I., Alvero, A., Chen, R., Chavez, S.L., Mor, G., Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy (2007) Am J Reprod Immunol, 57, pp. 55-66
• Abrahams, V.M., Kim, Y.M., Straszewski, S.L., Romero, R., Mor, G., Macrophages and apoptotic cell clearance during pregnancy (2004) Am J Reprod Immunol, 51, pp. 275-282
• Nagamatsu, T., Schust, D.J., The contribution of macrophages to normal and pathological pregnancies (2010) Am J Reprod Immunol, 63, pp. 460-471
• Aluvihare, V.R., Kallikourdis, M., Betz, A.G., Regulatory T cells mediate maternal tolerance to the fetus (2004) Nat Immunol, 5, pp. 266-271
• Terness, P., Kallikourdis, M., Betz, A.G., Rabinovich, G.A., Saito, S., Clark, D.A., Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells (2007) Am J Reprod Immunol, 58, pp. 238-254
• Leber, A., Teles, A., Zenclussen, A.C., Regulatory T cells and their role in pregnancy (2010) Am J Reprod Immunol, 63, pp. 445-459
• Zenclussen, A.C., Gerlof, K., Zenclussen, M.L., Sollwedel, A., Bertoja, A.Z., Ritter, T., Kotsch, K., Volk, H.D., Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model (2005) Am J Pathol, 166, pp. 811-822
• Ramhorst, R., Fraccaroli, L., Aldo, P., Alvero, A.B., Cardenas, I., Perez Leirós, C., Mor, G., Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells (2012) Am J Reprod Immunol, 67, pp. 17-27
• Saito, S., Nakashima, A., Shima, T., Ito, M., Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy (2010) Am J Reprod Immunol, 63, pp. 601-610
• Schumacher, A., Wafula, P.O., Teles, A., El-Mousleh, T., Linzke, N., Zenclussen, M.L., Langwisch, S., Zenclussen, A.C., Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells (2012) PLoS ONE, 7, pp. e42301
• Munoz-Suano, A., Hamilton, A.B., Betz, A.G., Gimme shelter: the immune system during pregnancy (2011) Immunol Rev, 241, pp. 20-38
• Warning, J.C., McCracken, S.A., Morris, J.M., A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system (2011) Reproduction, 141, pp. 715-724
• Rossi, D., Zlotnik, A., The biology of chemokines and their receptors (2000) Annu Rev Immunol, 18, pp. 217-242
• Bromley, S.K., Mempel, T.R., Luster, A.D., Orchestrating the orchestrators: chemokines in control of T cell traffic (2008) Nat Immunol, 9, pp. 970-980
• Fraccaroli, L., Alfieri, J., Pérez Leiros, C., Ramhorst, R., Immunomodulatory effects of chemokines during the early implantation window (2009) Front Biosc, 1, pp. 288-298
• Lutther, A.J., Cyster, A.C., Chemokines as regulators of T cell differentiation (2001) Nat Med, 2, pp. 102-107
• Moser, B., Loetscher, P., Lymphocyte traffic control by chemokines (2001) Nat Med, 2, pp. 123-128
• Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., Javitch, J.A., Parmentier, M., Springael, J.Y., Hetero-oligomerization of CCR2,CCR5, and CXCR4 and the protean effects of "selective" antagonists (2009) J Biol Chem, 284, pp. 31270-31279
• Raman, D., Sobolik-Delmaire, T., Richmond, A., Chemokines in health and disease (2011) Exp Cell Res, 317, pp. 575-589
• Neel, N.F., Barzik, M., Raman, D., Sobolik-Delmaire, T., Sai, J., Ham, A.J., Mernaugh, R.L., Richmond, A., VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis (2009) J Cell Sci, 122, pp. 1882-1894
• Raman, D., Neel, N.F., Sai, J., Mernaugh, R.L., Ham, A.J., Richmond, A.J., Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 "chemosynapse" (2009) Methods Enzymol, 460, pp. 315-330
• Raman, D., Sai, J., Neel, N.F., Chew, C.S., Richmond, A., LIM and SH3 protein-1 modulates CXCR2- mediated cell migration (2010) PLoS ONE, 5, pp. e10050
• Kallikourdis, M., Andersen, K.G., Welch, K.A., Betz, A.G., Alloantigen-enhanced accumulation of CCR5+ effector regulatory T cells in the gravid uterus (2007) PNAS, 104, pp. 594-599
• Mold, J.E., Michaëlsson, J., Burt, T.D., Muench, M.O., Beckerman, P.K., Busch, M.P., Lee, T., McCune, J.M., Maternal alloantigens promote the development of tolerogenic fetal regulatory t cells in utero (2008) Science, 322, pp. 1562-1565
• Mjösberg, J., Svensson, J., Johansson, E., Hellström, L., Casas, R., Jenmalm, M.C., Boij, R., Ernerudh, J., Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol (2009) J Immunol, 183, pp. 759-769
• Mjösberg, J., Berg, G., Jenmalm, M.C., Ernerudh, J., FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua (2010) Biol Reprod, 82, pp. 698-705
• Tilburgs, T., Roelen, D.L., van der Mast, B.J., de Groot-Swings, G.M., Kleijburg, C., Scherjon, S.A., Claas, F.H., Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy (2008) J Immunol, 180, pp. 5737-5745
• Tilburgs, T., Schonkeren, D., Eikmans, M., Nagtzaam, N.M., Datema, G., Swings, G.M., Prins, F., Claas, F.H., Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties (2010) J Immunol, 185, pp. 4470-4477
• Graham, C.H., Hawley, T.S., Hawley, R.G., MacDougall, J.R., Kerbel, R.S., Khoo, N., Lala, P.K., Establishment and characterization of first trimester human trophoblast cells with extended lifespan (1993) Exp Cell Res, 206, pp. 204-211
• Straszewski-Chavez, S.L., Abrahams, V.M., Alvero, A.B., Aldo, P.B., Ma, Y., Guller, S., Romero, R., Mor, G., The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71 (2009) Placenta, 30, pp. 939-948
• Nancy, P., Tagliani, E., Tay, C.S., Asp, P., Levy, D.E., Erlebacher, A., Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface (2012) Science, 336, pp. 1317-1321
• Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., Lusso, P., Identification of RANTES, MIP-1αand MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells (1995) Science, 270, pp. 1811-1815
• Hornung, D., Klingel, K., Dohrn, K., Kandolf, R., Wallwiener, D., Tayler, R.N., Regulated on activation, normal T-cell expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: assessment of autocrine/paracrine regulation by in situ hybridization (2001) Am J Pathol, 158, pp. 1949-1954
• Faunce, D., Stein-Streilein, J., NKT Cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance (2002) J Immunol, 169, pp. 31-38
• Nakamura, T., Sonoda, K., Faunce, D., Gumperz, J., Yamamura, T., Miyake, S., Stein-Streilein, T., CD4+ NKT cells, but not conventional CD4+ T cells are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site (2003) J Immunol, 171, pp. 1266-1271
• Rabinovich, G.A., Ramhorst, R.E., Rubinstein, N., Corigliano, A., Daroqui, M.C., Kier-Joffé, E.B., Fainboim, L., Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms (2002) Cell Death Differ, 9, pp. 661-670
• Ramhorst, R., Patel, R., Corigliano, A., Etchepareborda, J.J., Fainboim, L., Schust, D., Induction of maternal tolerance to fetal alloantigens by RANTES production (2006) Am J Reprod Immunol, 56, pp. 302-311
• Paria, B., Reese, J., Das, S., Dey, S., Deciphering the cross talk of implantation: advances and challenges (2002) Science, 296, pp. 2185-2188
• Fraccaroli, L., Alfieri, J., Larocca, L., Calafat, M., Mor, G., Pérez Leiros, C., Ramhorst, R., A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation (2009) Hum Reprod, 24, pp. 166-175
• Ramhorst, R., Gutiérrez, G., Corigliano, A., Junovich, G., Fainboim, L., Implication of RANTES in the modulation of alloimmune response by progesterone during pregnancy (2007) Am J Reprod Immunol, 57, pp. 147-152
• Kim, M.J., Romero, R., Kim, C.J., Tarca, A.L., Chhauy, S., LaJeunesse, C., Lee, D.C., Kim, J.S., Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease (2009) J Immunol, 182, pp. 3919-3927
• Fraccaroli, L., Grasso, E., Hauk, V., Cortelezzi, M., Calo, G., Pérez Leirós, C., Ramhorst, R., Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response (2012) Clin Exp Immunol, 170, pp. 310-320
• Said, S.I., The discovery of VIP: initially looked for in the lung, isolated from intestine, and identified as a neuropeptide (2007) Peptides, 28, pp. 1620-1621
• Couvineau, A., Laburthe, M., VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins (2012) Br J Pharmacol, 166, pp. 42-50
• Onoue, S., Misaka, S., Yamada, S., Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications (2008) Naunyn-Schmiedeberg's Arch Pharmacol, 377, pp. 579-590
• Harmar, A.J., Fahrenkrug, J., Gozes, I., Laburthe, M., May, V., Pisegna, J.R., Vaudry, D., Said, S.I., Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1 (2012) Br J Pharmacol, 166, pp. 4-17
• Delgado, M., Munoz-Elias, E.J., Gomariz, R.P., Ganea, D., Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation (1999) J Immunol, 162, pp. 4685-4696
• Gressens, P., Marret, S., Hill, J.M., Brenneman, D.E., Gozes, I., Fridkin, M., Evrard, P., Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain (1997) J Clin Invest, 100, pp. 390-397
• Månsson, B., Nilsson, B.O., Ekström, J., Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats (1990) Br J Pharmacol, 101, pp. 853-858
• Ekström, J., Mansson, B., Tobin, G., Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity (1983) Acta Physiol Scand, 119, pp. 169-175
• Jovanovic, S., Grbovic, L., Jovanovic, A., Pregnancy does not alter the response of uterine arteries to vasoactive intestinal polypeptide (2000) Mol Hum Reprod, 6, pp. 361-368
• Roca, V., Larocca, L., Calafat, M., Aisemberg, J., Meiss, R., Franchi, A., Perez Leiros, C., Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice (2006) Reproduction, 32, pp. 931-938
• Lara-Marquez, M., O'Dorisio, M., O'Dorisio, T., Shah, M., Karacay, B., Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells (2006) J Immunol, 166, pp. 2522-2530
• Martinez, C., Delgado, M., Abad, C., Gomariz, R.P., Ganea, D., Leceta, J., Regulation of VIP production and secretion by murine lymphocytes (1999) J Neuroimmunol, 93, pp. 126-138
• Li, J.M., Southerland, L., Hossain, M.S., Giver, C.R., Wang, Y., Darlak, K., Harris, W., Waller, E.K., Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice (2011) J Immunol, 187, pp. 1057-1065
• Lodde, B.M., Mineshiba, F., Wang, J., Cotrim, P., Afione, S., Tak, P.P., Baum, B.J., Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome (2006) Ann Rheum Dis, 65, pp. 195-200
• Delgado, M., Abad, C., Martinez, C., Leceta, J., Gomariz, R.P., Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease (2001) Nat Med, 7, pp. 563-568
• Gonzalez-Rey, E., Delgado, M., Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis (2007) Trends Mol Med, 13, pp. 241-251
• Yadav, M., Goetzl, E.J., Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity (2008) Ann N Y Acad Sci, 1144, pp. 83-89
• Jimeno, R., Gomariz, R.P., Gutiérrez-Cañas, I., Martínez, C., Juarranz, Y., Leceta, J., New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes (2010) Immunol Cell Biol, 88, pp. 734-745
• Rosignoli, F., Torroba, M., Juarranz, Y., Gomez, I.A., Martinez, C., Gomariz, R.P., Pérez Leirós, C., Leceta, J., VIP and tolerance induction in autoimmunity (2006) Ann N Y Acad Sci, 6, pp. 1-6
• Chorny, A., Gonzalez-Rey, E., Fernandez Martin, A., Ganea, D., Delgado, M., Vasointestinal peptide induces regulatory dendritic cells that prevent acute graft-host disease while maintaining the graft-versus tumor response (2006) Blood, 107, pp. 3787-3794
• Toscano, M.G., Delgado, M., Kong, W., Martin, F., Skarica, M., Ganea, D., Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs (2010) Mol Ther, 18, pp. 1035-1045
• Juarranz, M.G., Santiago, B., Torroba, M., Gutierrez-Cañas, I., Palao, G., Galindo, M., Abad, C., Gomariz, R.P., Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells (2004) Rheumatology, 43, pp. 416-422
• Carrión, M., Juarranz, Y., Pérez-García, S., Jimeno, R., Pablos, J.L., Gomariz, R.P., Gutiérrez-Cañas, I., RNA sensors in human osteoarthritis and rheumatoid arthritis synovial fibroblasts: immune regulation by vasoactive intestinal peptide (2011) Arthritis Rheum, 63, pp. 1626-1636
• Jimeno, R., Leceta, J., Martínez, C., Gutiérrez-Cañas, I., Pérez-García, S., Carrión, M., Gomariz, R.P., Juarranz, Y., Effect of VIP on the balance between cytokines and master regulators of activated helper T cells (2012) Immunol Cell Biol, 90, pp. 178-186
• Pozo, D., Anderson, P., Gonzalez-Rey, E., Induction of alloantigen-specific human T regulatory cells by vasoactive intestinal peptide (2009) J Immunol, 183, pp. 4346-4359
• Yadav, M., Rosenbaum, J., Goetzl, E.J., Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile (2008) J Immunol, 180, pp. 2772-2776
• Said, S.I., Hamidi, S.A., Gonzalez Bosc, L., Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? (2010) Eur Respir J, 35, pp. 730-734
• Leceta, J., Martínez, C., Delgado, M., Garrido, E., Gomariz, R.P., Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system (1996) Adv Neuroimmunol, 6, pp. 29-36
• Voice, J.K., Grinninger, C., Kong, Y., Bangale, Y., Paul, S., Goetzl, E.J., Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice (2003) J Immunol, 170, pp. 308-314
• Hill, J.M., McCune, S.K., Alvero, R.J., Glazner, G.W., Henins, K.A., Stanziale, S.F., Keimowitz, J.R., Brenneman, D.E., Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent (1996) J Clin Invest, 97, pp. 202-208
• Spong, C.Y., Lee, S.J., McCune, S.K., Gibney, G., Abebe, D.T., Brenneman, D.E., Hill, J.M., Regulation of postimplantation mouse embryonic growth by maternal vasoactive intestinal peptide (1999) Ann N Y Acad Sci, 897, pp. 101-108
• Spong, C., Lee, S., Mcune, S., Gibney, G., Abebe, D., Alvero, R., Brenneman, E., Hill, G., Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide (1999) Endocrinology, 140, pp. 917-924
• Hill, J.M., Hauser, J.M., Sheppard, L.M., Abebe, D., Spivak-Pohis, I., Kushnir, M., Deitch, I., Gozes, I., Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry (2007) J Mol Neurosci, 31, pp. 183-200
• Gressens, P., Paindaveine, B., Hill, J.M., Evrard, P., Brenneman, D.E., Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos (1994) Eur J Neurosci, 10, pp. 1734-1742
• Tyrrell, S., Landis, S.C., The appearance of NPY and VIP in sympathetic neuroblasts and subsequent alterations in their expression (1994) J Neurosci, 14, pp. 4529-4547
• Lim, M.A., Stack, C.M., Cuasay, K., Stone, M.M., McFarlane, H.G., Waschek, J.A., Hill, J.M., Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior (2008) Int J Dev Neurosci, 26, pp. 423-434
• Graf, A.H., Hütter, W., Hacker, G.W., Steiner, H., Anderson, V., Staudach, A., Dietze, O., Localization and distribution of vasoactive neuropeptides in the human placenta (1996) Placenta, 17, pp. 413-421
• Marzioni, D., Fiore, G., Giordano, A., Nabissi, M., Florio, P., Verdenelli, F., Petraglia, F., Castellucci, M., Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release (2005) J Clin Endocrinol Metab, 90, pp. 2378-2383
• Deutsch, P.J., Sun, Y., Kroog, G.S., Vasoactive intestinal peptide increases intracellular cAMP and gonadotropin-alpha gene activity in JEG-3 syncytial trophoblasts. Constraints posed by desensitization (1990) J Biol Chem, 265, pp. 10274-10281
• Ottesen, B., Ulrichsen, H., Fahrenkrug, J., Larsen, J.J., Wagner, G., Schierup, L., Søndergaard, F., Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery (1982) Am J Obstet Gynecol, 143, pp. 414-420
• Roca, V., Calafat, M., Larocca, L., Ramhorst, R., Farina, M., Franchi, A.M., Pérez Leiros, C., Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice (2009) Reproduction, 138, pp. 733-742
• Larocca, L., Hauk, V., Calafat, M., Roca, V., Fraccaroli, L., Franchi, A., Ramhorst, R., Pérez Leiros, C., Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice (2011) Mol Cell Endocrinol, 333, pp. 112-118
• Fraccaroli, L., Alfieri, J., Larocca, L., Calafat, M., Roca, V., Lombardi, E., Ramhorst, R., Pérez Leirós, C., VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells (2009) Br J Pharmacol, 156, pp. 116-126
• Fraccaroli, L., Grasso, E., Zeitler, E., Lombardi, E., Gogorza, S., Etchepareborda, J.J., Nagle, C., Ramhorst, R., Modulation of maternal LIF producers T cells by trophoblast and paternal antigens (2011) Am J Reprod Immunol, 65, pp. 133-145
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10, pp. 981-991
• Ramhorst, R.E., Giribaldi, L., Fraccaroli, L., Toscano, M.A., Stupirski, J.C., Romero, M.D., Durand, E.S., Rabinovich, G.A., Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss (2012) Glycobiology, 22, pp. 1374-1386
• Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Arck, P.C., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat Med, 13, pp. 1450-1457
• Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335
• Than, N.G., Romero, R., Kim, C.J., McGowen, M.R., Papp, Z., Wildman, D.E., Galectins: guardians of eutherian pregnancy at the maternal-fetal interface (2012) Trends Endocrinol Metab, 23, pp. 23-31
• Than, N.G., Erez, O., Wildman, D.E., Tarca, A.L., Edwin, S.S., Abbas, A., Hotra, J., Romero, R., Severe preeclampsia is characterized by increased placental expression of galectin-1 (2008) J Matern Fetal Neonatal Med, 21, pp. 429-442

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------